Emendo Biotherapeutics vs Sherman Diagnostics
Emendo Biotherapeutics vs Sherman Diagnostics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Sherman Diagnostics on 42/100.
Where each one leads
Emendo Biotherapeutics
- our overall score: 59/100 against 42/100
- domain rating: 20/100 against 2/100
Sherman Diagnostics
- agent readiness: 50/100 against 40/100
At a glance
| Measure | Emendo Biotherapeutics | Sherman Diagnostics |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | Next-generation molecular diagnostics for immediate and accurate pathogen detection anywhere. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Healthcare, Diagnostics, MedTech, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Hardware |
| Founded | 2015 | 2020 |
| Headquarters | Tel Aviv, Israel | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Sherman Diagnostics |
|---|---|---|
| Employees | 41 | Not published |
| Headcount growthLast 12 months | -16.1% | Not published |
| Total funding | $61.0M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 5,333 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Sherman Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 42/100 |
| Traction | 55/100 | Not published |
| Team | 40/100 | 70/100 |
| Search visibility | 44/100 | 6/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 2/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Sherman Diagnostics |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CMS | WordPress | Wix |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Emendo Biotherapeutics vs Sherman Diagnostics: common questions
Which is better, Emendo Biotherapeutics or Sherman Diagnostics?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Sherman Diagnostics compare on the numbers?
Emendo Biotherapeutics leads on our overall score (59/100 against 42/100), domain rating (20/100 against 2/100). Sherman Diagnostics leads on agent readiness (50/100 against 40/100).
Read the full Emendo Biotherapeutics review and pricing or the Sherman Diagnostics review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.